| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 690116 | Null | 0.0019098098157241 | 0.31856295 |
| NSC 69852 | 1,4-Butanediamine, N,N'-bis(3-aminopropyl)-, tetrahydrochloride (8CI9CI) | 0.0019098098157241 | 0.28354707 |
| NSC 703318 | Null | 0.0019098098157241 | 0.10872086 |
| NSC 722985 | Null | 0.0019098098157241 | 0.12413478 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0019098098157241 | 0.33819276 |
| NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.0019098098157241 | 0.14423884 |
| NSC 732698 | 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne | 0.0019098098157241 | 0.32063149 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0019098098157241 | 0.38808817 |
| NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.0019098098157241 | 0.44611239 |
| NSC 743432 | 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.0019098098157241 | 0.29178143 |